Elisabeth Bjork is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 40,000 shares of RCKT, which is worth approximately $126,400. The most recent transaction as insider was on Aug 27, 2025, when has been sold 10,000 shares (Common Stock) at a price of $3.41 per share, resulting in proceeds of $34,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40K
n/a 3M change
n/a 12M change
Total Value Held $126,400

Elisabeth Bjork Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 27 2025
BUY
Open market or private purchase
$34,100 $3.41 p/Share
10,000 Added 20.0%
40,000 Common Stock
Jun 18 2025
BUY
Grant, award, or other acquisition
-
30,000 Added 50.0%
30,000 Common Stock
EB

Elisabeth Bjork

Cranbury, NY

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT